The Justice Department this month intervened in two whistleblower cases involving SpineFrontier Inc., related entities and executives. It is alleged that kickbacks were paid to spine surgeons to induce them to use SpineFrontier’s surgical devices, a violation of the Anti-Kickback Statute (AKS). The AKS prohibits offering, paying, soliciting, or receiving remuneration to induce referrals of…

Read More

Teva Pharmaceuticals earlier this month agreed to pay $54 million to settle a whistleblower lawsuit brought against it by two former sales representatives. Charles Arnstein and Hossam Senousy filed suit against the Israeli-based pharmaceutical company alleging it paid speaker fees to neurologists for participation in “sham” speaker programs in exchange for their prescribing the multiple…

Read More

Last year, we wrote about an internal memo from the U.S. Department of Justice addressing the dismissal of qui tam (whistleblower) cases. The Granston Memo, so named because it was written by DOJ’s Director of Civil Fraud Section Michael Granston, outlined various factors government prosecutors should use to evaluate whether a False Claims Act (FCA)…

Read More